Treating Early and Often: Targeted Therapeutics in the Adjuvant Setting

JCO Precis Oncol. 2023 Sep:7:e2300551. doi: 10.1200/PO.23.00551.

Author

Shridar Ganesan¹

Affiliation

¹ Rutgers Cancer Institute of New Jersey, Department of Medicine and Pharmacology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ.

PMID: 38096471
PMCID: PMC10730077 (available on 2024-12-14)
DOI: 10.1200/PO.23.00551

No abstract available

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*

Grants and funding